**Core tip:** For portal hypertension, idealized portal vein (PV) modeling showed a significantly lower wall shear stress (WSS) in both sides of the PV and the occurrence of disturbed flow in the left wall of the PV. In addition, greater risk of disturbed flow was found for smaller PV-splenic vein (SV) angle and larger superior mesenteric vein-SV angle. In patient-specific models, WSS in cirrhotic patients with portal hypertension was markedly lower than that in healthy controls and disturbed flow was more likely to occur in the portal hypertension patients.

INTRODUCTION
============

The morbidity and mortality of liver cirrhosis have been increasing in developed countries, with this disease currently representing one of the most common causes of death in adults worldwide\[[@B1]\]. A severe complication of liver cirrhosis is portal hypertension, which can lead to gastroesophageal varices, ascites and hepatic encephalopathy. Indeed, portal hypertension has emerged as the leading cause of mortality and liver transplantation in cirrhotic patients\[[@B2]\].

Pathological progress from chronic liver disease to cirrhosis is accompanied by architectural and structural changes in the hepatic microvascular system, including sinusoidal remodeling, intrahepatic shunt formation and hepatic endothelial dysfunction. As a result, intrahepatic resistance is increased; itself the initial and primary factor underlying increase in portal pressure that is characteristically observed in patients with cirrhosis. Unfortunately, the sequential adaptive response of splanchnic vasodilation (to increase liver blood supply) can serve to aggravate portal vein (PV) pressure. In patients with advanced cirrhosis, an intensively high portal hypertension (characterized by hyperdynamic splanchnic and systemic circulation) can lead to formation of portal-systemic collaterals and other complications\[[@B3]\]. The mean PV blood flow velocity is lower in cirrhotic patients than in healthy subjects, and Zironi et al\[[@B4]\] found that the mean velocity dropped from 19.6 ± 2.6 cm/s in normal subjects to 13.0 ± 3.2 cm/s in patients with cirrhosis. Finally, it is intriguing that abnormal PV hemodynamic changes are also closely related to PV thrombosis, a complication of advanced liver disease, but the mechanism remains to be elucidated\[[@B5],[@B6]\].

Recently, the study of abnormal hemodynamic changes in atherosclerosis has gained considerable attention, with its occurrence being purported as a plausible explanation for atherosclerotic plaque formation\[[@B7]\]. This theory is based on the observation that the location of abnormal flow rate fits well with presence of vascular inflammation and distribution of the atherosclerotic plaques. In general, blood flow mainly shows its effect on vessels, especially on the endothelial cells that make them up, by wall shear stress (WSS), which may involve a multitude of physical and molecular mechanisms\[[@B8]-[@B10]\].

Abnormal hemodynamic changes have been observed in cirrhotic patients. However, whether these hemodynamic changes, especially those related to WSS, have effects on PV thrombosis in cirrhotic patients with portal hypertension remains unclear. The present study was, therefore, designed to illustrate the magnitude and distribution of WSS in PV in cirrhotic patients with portal hypertension.

Computational fluid dynamics (CFD) is a specialist area of mathematics and a branch of fluid mechanics that has been increasingly applied to cardiovascular research areas. Its greatest benefit has been to facilitate investigations into pressure and flow fields, in temporal and spatial manners, that had been previously unachievable by the traditional methods of measurement\[[@B11]\]. Botar et al\[[@B12]\] used the Reynolds stress equation model to simulate hemodynamics in the PV system. We previously applied the CFD approach to reconstruct both idealized and patient-specific models, thereby illustrating that liver right-lobe atrophy and left-lobe hypertrophy is significantly influenced by the different distribution of blood from splenic vein (SV) and superior mesenteric vein (SMV) in patients with portal hypertension as compared to healthy control subjects\[[@B13]\]. When interpreting our findings from that previous CFD study and determining how to best build upon them, we considered the study by Van Steenkiste et al\[[@B14]\], in which vascular corrosion casting was used to analyze WSS in the PV of rodents with portal hypertension and cirrhosis.

In the present study, we constructed an idealized PV model and patient-specific models; the latter of which based on enhanced computed tomography (CT) images from 10 cirrhotic patients with portal hypertension and five healthy control subjects. We analyzed the WSS distribution in these models by using CFD.

MATERIALS AND METHODS
=====================

Idealized PV modeling
---------------------

The PV system consists of the SV and SMV, which join to form the PV itself. The PV then goes into the liver, where it branches into the left PV (LPV) and right PV (RPV). First, we constructed an idealized but physically representative model of the PV system (Figure [1](#F1){ref-type="fig"}). The vessel geometric parameters (Table [1](#T1){ref-type="table"}) were determined according to clinical data and literature\[[@B15]\], which showed that the angle between the SV and SMV ranges from 85° to 135°, while the angle between the SV and PV ranges from 90° to 130°.

###### 

Geometric and hemodynamic parameters of the idealized portal vein system model

  **Vein**   **Length (cm)**   **Diameter (cm)**   **Inlet velocity (cm/s)**        
  ---------- ----------------- ------------------- --------------------------- ---- ----
  PV         5.1               1.03                1.31                        \-   \-
  SV         9.6               0.63                0.95                        17   16
  SMV        8.2               0.92                0.94                        21   17
  LPV        2.1               0.73                0.75                        \-   \-
  RPV        2.1               0.83                0.78                        \-   \-

PV: Portal vein; SV: Splenic vein; SMV: Superior mesenteric vein; LPV: Left PV; RPV: Right PV.

![Geometry of the portal vein system. A: Enhanced CT of the portal vein (PV) system; B: Geometry of the idealized PV model. SV: Splenic vein; SMV: Superior mesenteric vein; LPV: Left PV; RPV: Right PV.](WJG-23-3279-g001){#F1}

We constructed and meshed the idealized models using GAMBIT 2.4.0 software. The resultant models were imported into Fluent 6.3 CFD software (Ansys), which was used to calculate the blood flow field. The WSS visualization was achieved with Tecplot 360 software.

The idealized models were divided into a control group and a portal hypertension group. The diameters of the different vessels and the velocities of the inlet vessels for those two groups are listed in Table [1](#T1){ref-type="table"}. We first compared the magnitude and distribution of WSS in the control group idealized model with those in the portal hypertension group idealized model. Then, we examined a variety of SMV-SV angles (85°, 95° and 105°) and PV-SV angles (90°, 110° and 130°) to study their respective effects on WSS (Figure [1B](#F1){ref-type="fig"}).

Patient-specific modeling
-------------------------

Imaging data from all subjects were collected from enhanced CT images obtained by the GE LightSpeed 16-slice CT scanner (GE Healthcare, United States) in The Second Affiliated Hospital of Xi'an Jiaotong University between March and October 2016. The clinical characteristics of the patients diagnosed with liver cirrhosis\[[@B1]\] (liver biopsy confirmed) and portal hypertension and of the healthy controls (no history of liver disease) are presented in Table [2](#T2){ref-type="table"}. All patients had hypersplenism and history of gastrointestinal bleeding, and many of the patients had undergone splenectomy and esophagogastric devascularization. This research was approved by the Ethical Committee of The Second Affiliated Hospital of Xi'an Jiaotong University and all enrolled subjects provided written informed consent for study participation and publication of related data.

###### 

Clinical characteristics of patients with cirrhosis and portal hypertension and healthy controls

  **Parameters**              **Cirrhotic** **(*n* = 10)**   **Non-cirrhotic** **(*n* = 5)**   ***P* value**
  --------------------------- ------------------------------ --------------------------------- ---------------
  Sex, M/F                    7/3                            3/2                               0.73
  Age, yr                     41 (31-58)                     40 (29-53)                        0.85
  AST, in UI/L                52 (44-61)                     30 (25-35)                        0.01
  ALT, UI/L                   44 (41-56)                     30 (28-31)                        0.01
  Platelet count, × 10^9^/L   48 (42-57)                     235 (206-265)                     \< 0.01
  Diameter, in mm                                                                              
  PV                          12.9 (11.0-14.3)               10.3 (9.9-10.7)                   0.02
  SV                          10.0 (8.4-10.2)                6.3 (6.1-6.5)                     \< 0.01
  SMV                         8.6 (7.7-10.7)                 9.3 (8.9-9.6)                     0.77

Data are shown as median (interquartile range), except for age shown as median (range). ALT: Alanine transaminase; AST: Aspartate transaminase.

All CT scans were performed in a supine position, and the scanning area encompassed the SMV to the bifurcation of the first porta hepatis. For each subject, each scan produced 320 layers of images with a thickness of 0.5 mm. We selected the PV phase CT images to construct the 3D models.

The geometry of the patient-specific PV models was constructed by using Mimics software for CFD analysis (Materialise, Belgium), as shown in Figure [2](#F2){ref-type="fig"}. To facilitate the hemodynamic calculation, some small parts were pruned during the 3D reconstruction, so that only the PV and its main branches (SV, SMV, LPV and RPV) were retained. Gambit 2.4.0 software was used to remesh the geometric models; after which, the models were imported into Fluent 6.3 software to calculate the blood flow.

![Geometry of the patient-specific portal vein model. A: Healthy control; B: Cirrhotic patient with portal hypertension.](WJG-23-3279-g002){#F2}

Numerical simulation
--------------------

CFD simulations were performed by using finite-element analysis under the governing equations of mass and momentum conservation. Because the PV starts far from the heart, the influence of the cardiac cycle is negligible and can be ignored. For simplicity, the blood in the PV system demonstrated laminar flow and was assumed to be an incompressible isothermal Newtonian fluid, with a gravity of 1050 kg/m^3^ and a viscosity of 4.5 × 10^-3^ N/m^2^/s. The vessel wall was regarded as rigid, without slip conditions or viscoelastic properties. The boundary conditions used in all models were a constant inlet velocity for the SV and SMV.

For the idealized PV model, the average axial velocities of blood flow in the SMV and SV are listed in Table [1](#T1){ref-type="table"} for the portal hypertension and control groups. For the patient-specific PV model, the average axial velocities of blood flow in the SMV and SV of the cirrhotic patients with portal hypertension and the healthy controls were determined according to individuals' results of testing by Doppler ultrasound. A traction-free boundary condition was applied to the outlets. The outflow was weighted according to the values reported in the literature: 0.6 for the RPV and 0.4 for the LPV. WSS distributions were calculated from the velocity field data.

Data analysis
-------------

Data are represented as median or interquartile range, except for age (median and range). The WSS in patient-specific models are presented as mean ± SD. The magnitude and distribution of WSS were recorded in all idealized models and patient-specific models. The WSS between cirrhotic patients and normal subjects in the patient-specific model was compared using the Mann-Whitney *U* test. Analyses were carried out using SPSS version 19.0 (IBM, Chicago, IL, United States). Statistical significance was defined as two-tailed *P* \< 0.05.

RESULTS
=======

Differential distribution of WSS in idealized PV models of portal hypertension and control groups
-------------------------------------------------------------------------------------------------

To calculate the magnitude and distribution of WSS in the portal hypertension and control groups, we first constructed idealized PV models (Figure [1](#F1){ref-type="fig"}) according to geometric parameters, and then imported inlet velocities (Table [1](#T1){ref-type="table"}) into Fluent 6.3.0. Figure [3](#F3){ref-type="fig"} shows that WSS in the PV right wall was higher than that in the left wall, in both the portal hypertension and control groups. In the PV right wall, WSS was significantly decreased in the portal hypertension group (5-20 dyn/cm^2^) as compared to the control group (15-30 dyn/cm^2^). In the PV left wall, WSS dropped from 5-15 dyn/cm^2^ in the control group to 0-5 dyn/cm^2^ in the portal hypertension group, and WSS dropped to 0, demonstrating the possibility of disturbed flow. Table [3](#T3){ref-type="table"} lists the mean WSS in left and right walls of the PV in the portal hypertension and control groups.

###### 

Wall shear stress in left and right walls of the portal vein in control and portal hypertension groups

                   **Control group**   **PH group**         
  ---------------- ------------------- -------------- ----- -----
  WSS, dyn/cm^2^   16.3                8.6            9.8   4.4

Data are shown as median. PH: Portal hypertension. WSS: Wall shear stress.

![Wall shear stress distribution in right wall (A) and left wall (B) in the healthy control and portal hypertension groups. The X axis shows the length of the side wall of the PV, starting from 0 in the junction of SV and SMV. The Y axis shows WSS. SV: Splenic vein; SMV: Superior mesenteric vein.](WJG-23-3279-g003){#F3}

Differential effects of SMV-SV and PV-SV angles on WSS distribution in idealized PV models
------------------------------------------------------------------------------------------

Due to the complicity and variation of the PV system that exists among individuals in real life, we investigated the effects of different SMV-SV and PV-SV angles on WSS distribution in the PV. According to the ranges of real-life angles for PV-SV and SMV-SV, we selected 90°, 110° and 130° to examine the former and 85°, 105° and 125° to examine the latter by idealized models. As shown in Figure [4](#F4){ref-type="fig"}, the effects of SMV-SV angle variation mainly involved the proximal portion of the PV. The magnitude of WSS was found to decrease as the angle increased in the PV right wall, but no similar change was found in the PV left wall. WSS distribution in the proximal left wall changed when the angle increased, supporting the possibility of disturbed flow occurrence. In the right wall, a greater possibility of disturbed flow followed with the angle \> 125°. Table [4](#T4){ref-type="table"} shows the mean WSS in the right wall and left wall of the PV for the different SMV-SV angles.

###### 

Wall shear stress in right and left walls for different superior mesenteric vein-splenic vein angles

                   **Right wall**   **Left wall**                   
  ---------------- ---------------- --------------- --- ----- ----- -----
  WSS, dyn/cm^2^   16.3             12.1            9   8.6   8.7   9.4

Data are shown as median. WSS: Wall shear stress.

![Wall shear stress distribution in right wall (A) and left wall (B) for different superior mesenteric vein-splenic vein angles. The X axis shows the length of the side wall of PV, starting from 0 in the junction of SV and SMV. The Y axis shows WSS. SV: Splenic vein; SMV: Superior mesenteric vein.](WJG-23-3279-g004){#F4}

The effects of PV-SV angle variation also mainly involved the proximal portion of the PV (Figure [5](#F5){ref-type="fig"}). As the angle increased, the magnitude of WSS decreased in the right wall but increased in the left wall. Moreover, disturbed flow occurred with PV-SV angle of 90°, disappearing with any increase in the angle. Table [5](#T5){ref-type="table"} shows the mean WSS in the right wall and left wall of the PV for the different PV-SV angles.

###### 

Wall shear stress in left and right walls for different portal vein-splenic vein angles

                   **Right wall**   **Left wall**                      
  ---------------- ---------------- --------------- ------ ----- ----- -----
  WSS, dyn/cm^2^   13.7             16.3            13.3   6.9   8.6   9.7

Data are shown as median. WSS: Wall shear stress.

![Wall shear stress distribution in right wall (A) and left wall (B) for different portal vein-splenic vein angles. The X axis shows the length of the side wall of PV, starting from 0 in the junction of SV and SMV. The Y axis shows WSS. SV: Splenic vein; SMV: Superior mesenteric vein.](WJG-23-3279-g005){#F5}

Patient-specific models
-----------------------

To simulate the WSS in real-life PV systems, we reconstructed patient-specific models from 10 patients with cirrhotic portal hypertension and five healthy subjects who served as controls. The clinical data for each group is shown in Table [2](#T2){ref-type="table"}, which includes the finding that the SV and PV diameters in the patients were significantly larger than those in the controls, and that the SMV diameter did not differ between patients and healthy subjects.

Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"} show the WSS distributions in the PV systems of the patients and controls. The mean WSS in the patients (10.13 ± 1.34 dyn/cm^2^) was significantly higher than that in the controls (19.06 ± 2.63 dyn/cm^2^), and these results agree well with those from the idealized model simulations (*P* \< 0.05). Disturbed flow occurred more readily in low shear stress areas. In the controls, low shear stress areas were found in the junctional area of SV and SMV into the PV, the divided area of the PV into LPV and RPV, and the outer wall of curving SV. In the patients, low shear stress areas extended wider and the magnitude of WSS was lower, signifying a greater propensity towards occurrence of disturbed flow.

![Portal vein system wall shear stress distribution in healthy controls (A) and cirrhotic patients with portal hypertension (B).](WJG-23-3279-g006){#F6}

![Mean wall shear stress of portal vein in healthy controls (Con) and cirrhotic patients with portal hypertension. ^a^*P* \< 0.05 *vs* healthy controls.](WJG-23-3279-g007){#F7}

DISCUSSION
==========

Hemodynamic changes, especially WSS, create adverse effects in cardiovascular disease. As a preliminary study to illuminate whether biomechanical forces have effects on hepatic PV diseases, such as PV thrombosis, we reconstructed idealized PV models and patient-specific models and quantified the magnitude and distribution of WSS in portal hypertension patients for comparison with those of healthy controls. We found that the magnitude of WSS in the portal hypertension group was significantly lower than that in the healthy control group (both for idealized and the patient-specific modeling).

The magnitude and distribution of WSS have been investigated in the cardiovascular system. These studies generally use Poiseuille's law to determine the magnitude of WSS\[[@B16]\]. According to literature, the WSS ranges from 1 to 6 dyn/cm^2^ in the venous system and from 10 to 79 dyn/cm^2^ in the arterial system\[[@B17]\]. Among the CFD-based research studies of the cardiovascular system, Soulis et al\[[@B18]\] reported simulating the WSS in the normal left coronary tree; their results indicated high WSS regions occurring often at all flow dividers and low WSS regions (7.5-22.5 dyn/cm^2^) occurring at bifurcations opposite the flow dividers. Shojima et al\[[@B19]\] reported findings that WSS in the vessel region of a middle cerebral artery aneurysm was significantly lower than that in the neck region (36.4 ± 12.5 *vs* 143.9 ± 62.1 dyn/cm^2^) and markedly higher than that in the aneurysm region (16.4 ± 11.6 dyn/cm^2^). Tang et al\[[@B20]\] showed that WSS in pulmonary arterial hypertension patients is significantly lower than in controls (4.3 ±2.8 *vs* 20.5 ± 4.0 dyn/cm^2^) for the central pulmonary artery, unlike the distal artery which showed no difference.

In the current study, we found that WSS in cirrhotic patients was significantly lower than in healthy controls. Low WSS area, which carries a greater possibility of disturbed flow, was found to most often occur with larger PV-SMV angle and smaller PV-SV angle. We also found that the low WSS area often occurred in the junction area of SV and SMV into PV, the divided area of PV into LPV and RPV, and the outer wall of curving SV for the healthy controls, and that this area extended wider and had lower magnitude in the cirrhotic patients with portal hypertension.

Endothelial cells are constantly exposed to WSS, which is known to be able to trigger and regulate various endothelial cell functions. Clinical studies have found that atherosclerotic plaques preferentially develop at regions with disturbed flow and low WSS, such as branches, bifurcations and curvatures\[[@B21]-[@B23]\]. Under conditions of oscillatory and low WSS, endothelial cells have been shown to have a proinflammatory phenotype, with increased procoagulant and proadhesive properties and decreased production of nitric oxide\[[@B24]\].

In the development of portal hypertension, endothelial dysfunction plays fundamental roles in initiating intrahepatic vascular resistance; moreover, liver sinusoidal endothelial cells attain a hypoactive phenotype that is characterized by decreased production of nitric oxide\[[@B25]\]. Furthermore, PV thrombosis reportedly has higher prevalence (0.6%-15.8%) in cirrhotic patients with portal hypertension, and reduced portal flow velocity has been proposed as the most important predictive parameter of this condition\[[@B5]\]. To date, however, there is no such research about the effects of abnormal PV system WSS on endothelial dysfunction, nor on whether the dysfunctional endothelial cells play important roles in PV diseases, such as PV thrombosis. Our simulation data fill this gap in the field and may serve as a basis for future *in vitro* studies.

However, several limitations inherent to the study design must be considered when extrapolating our findings. First, our real-life study population included a small number of cirrhotic patients with portal hypertension. Moreover, we enrolled only patients waiting for splenectomy; as such, our results cannot be generalized to patients with mild to moderate portal hypertension. In addition, other portal hypertension patients were excluded. Second, the correlation between low WSS areas and PV thrombosis locations has not yet been clarified.

Despite these limitations, several conclusions can be drawn based upon careful consideration of the available data. Cirrhotic patients with portal hypertension present noticeable hemodynamic changes, which were indicated by lower WSS and a greater likelihood of disturbed flow. Future investigations on this topic should be designed with a stratification approach, to further differentiate portal hypertension patients, for example, according to severity of their disease in order to determine the specificity and sensitivity of WSS and its clinical applicability.

COMMENTS
========

Background
----------

Hemodynamic changes, especially wall shear stress (WSS), create adverse effects on endothelial function in cardiovascular disease. Endothelial dysfunction and abnormal hemodynamic changes are known to play important roles in portal hypertension, which may lead to portal vein (PV)-associated diseases, such as PV thrombosis. However, there is sparse research on the distribution of WSS in the PV system in portal hypertension, the effects of abnormal PV system WSS on endothelial dysfunction, and whether the dysfunctional endothelial cells play important roles in PV diseases.

Research frontiers
------------------

This study demonstrated that WSS was significantly lower in both sides of the PV for the portal hypertension group as compared with the normal controls, shown by idealized PV modeling. Moreover, disturbed flow was more prone to occur in the left wall of the PV in the portal hypertension group. In addition, greater risk of disturbed flow was found for smaller PV-splenic vein (SV) angle and larger superior mesenteric vein-SV angle. In patient-specific models, WSS in cirrhotic patients with portal hypertension was markedly lower than that in healthy controls and disturbed flow was more likely to occur in the portal hypertension patients.

Innovations and breakthroughs
-----------------------------

This research simulated the magnitude and distribution of WSS using both idealized PV models and patient-specific models and found that WSS was significantly lower in cirrhotic portal hypertension patients than in healthy controls and disturbed flow was more prone to occur in portal hypertension patients.

Applications
------------

This simulation data can fill the current gap in the field of WSS distribution in cirrhotic portal hypertension patients and may serve as a basis for future *in vitro* studies to explore the effects of abnormal WSS in portal hypertension on endothelial dysfunction and PV diseases, such as PV thrombosis.

Terminology
-----------

WSS is generated by blood flow viscosity acting upon the luminal vessel wall and exerts a frictional force per unit on endothelial surface of vessels. Computational fluid dynamics is a specialist area of mathematics and a branch of fluid mechanics; its greatest benefit has been to facilitate investigations into pressure and flow fields, in temporal and spatial manners that had been previously unachievable by the traditional methods of measurement.

Peer-review
-----------

This is a study regarding WSS simulation in cirrhotic portal hypertension patients using computational fluid dynamics. Generally, the simulation was performed properly and the manuscript was well-written. The main findings are quite novel and can provide basic data to simulate portal hypertension WSS for future *in vitro* studies.
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